Physician profile
Ram Narayan
NPI 1376954693
$1,590.77
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.05 · 2020: $24.66 · 2021: $185 · 2022: $115 · 2023: $159 · 2024: $1,050.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,050 · Education: $83.99 · Food and Beverage: $75.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,050.00 |
| Education | $83.99 |
| Food and Beverage | $75.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,050.00 | 2024 | Imfinzi, Tagrisso |
| Myriad Genetic Laboratories, INC. | $169.24 | 2021-2023 | Prolaris |
| Seagen INC. | $101.24 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $40.42 | 2021 | |
| Cardinal Health 414 LLC | $35.16 | 2023 | |
| Boston Scientific Corporation | $24.66 | 2020 | |
| Myovant Sciences INC. | $20.87 | 2022 | |
| Novartis Pharmaceuticals Corporation | $18.80 | 2022 | |
| Novocure INC. | $16.43 | 2019 | |
| Arbor Pharmaceuticals, INC. | $15.51 | 2022 | |
| Gilead Sciences, INC. | $15.30 | 2023 | Trodelvy |
| Amag Pharmaceuticals, INC. | $14.95 | 2019 | |
| Medtronic, INC. | $14.61 | 2022 | |
| Blue Earth Diagnostics | $14.54 | 2022 | |
| Amgen INC. | $14.16 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $13.37 | 2022 | |
| Puma Biotechnology, INC. | $11.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ram Narayan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.